Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × Resveratrol × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1

Interventions

Cisplatin 245 Carboplatin 173 Oxaliplatin 163 Capecitabine 160 Docetaxel 157 apatinib 152 Paclitaxel 145 Gemcitabine 138 Bevacizumab 135 Radiotherapy 132 camrelizumab 129 Fluorouracil 127 Cyclophosphamide 116 Irinotecan 109 Drug Therapy 93 Etoposide 92 sintilimab 89 S 1 (combination) 77 Leucovorin 73 anlotinib 71 Doxorubicin 70 pembrolizumab 69 toripalimab 66 tislelizumab 66 Pemetrexed 66 Dexamethasone 62 Rituximab 61 Neoadjuvant Therapy 59 Cetuximab 58 Trastuzumab 57

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡